|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q3 FY2021
As of Sep 30, 2021
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||||||||||||||
| Cash and due from banks | ||||||||||||||||||||
| Interest bearing deposits with banks | ||||||||||||||||||||
| Cash and cash equivalents | ||||||||||||||||||||
| Equity securities | ||||||||||||||||||||
| Debt securities available for sale | ||||||||||||||||||||
| Debt securities held to maturity (fair value $172,623 and $179,984, respectively) | ||||||||||||||||||||
| Restricted investment in bank stock | ||||||||||||||||||||
| Total loans | ||||||||||||||||||||
| Less: Allowance for credit losses | ||||||||||||||||||||
| Total loans, net of allowance for credit losses | ||||||||||||||||||||
| Premises and equipment, net | ||||||||||||||||||||
| Other real estate owned | ||||||||||||||||||||
| Bank owned life insurance and annuities | ||||||||||||||||||||
| Investment in low-income housing partnerships | ||||||||||||||||||||
| Core deposit and other intangible assets | ||||||||||||||||||||
| Goodwill included in acquisition price | ||||||||||||||||||||
| Mortgage servicing rights | ||||||||||||||||||||
| Deferred tax asset, net | ||||||||||||||||||||
| Accrued interest receivable and other assets | ||||||||||||||||||||
| Total assets | ||||||||||||||||||||
| Liabilities: | ||||||||||||||||||||
| Non-interest bearing | ||||||||||||||||||||
| Interest bearing | ||||||||||||||||||||
| Total deposits | ||||||||||||||||||||
| Short-term borrowings and repurchase agreements | ||||||||||||||||||||
| Long-term debt | ||||||||||||||||||||
| Other interest bearing liabilities | ||||||||||||||||||||
| Accrued interest payable and other liabilities | ||||||||||||||||||||
| Total liabilities | ||||||||||||||||||||
| Stockholders' Equity: | ||||||||||||||||||||
| Preferred stock, no par value: Authorized - 500,000 shares, none issued | ||||||||||||||||||||
| Common stock, par value $1.00 per share: Authorized 20,000,000 shares; Issued - 5,151,279 shares at June 30, 2026 and December 31, 2025; Outstanding - 5,034,291 shares at June 30, 2026 and 5,018,799 shares at December 31, 2025 | ||||||||||||||||||||
| Surplus | ||||||||||||||||||||
| Retained earnings | ||||||||||||||||||||
| Accumulated other comprehensive loss | ||||||||||||||||||||
| Cost of common stock in Treasury: 116,988 shares at June 30, 2026; 132,480 shares at December 31, 2025 | ||||||||||||||||||||
| Total stockholders' equity | ||||||||||||||||||||
| Total liabilities and stockholders' equity | ||||||||||||||||||||
Loading...
